Latest Breaking News On - Biotechnology molecular engineering - Page 1 : comparemela.com

2seventy stock rises as Regeneron acquires R&D assets (NASDAQ:REGN)

2seventy stock rises as Regeneron acquires R&D assets (NASDAQ:REGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Philip gregoryRegeneron pharmaceuticalsBiotechnology molecular engineeringRegeneron cell medicinesRegeneron cell

Blueprint Medicines: Looking Toppy (NASDAQ:BPMC)

Blueprint Medicines: Looking Toppy (NASDAQ:BPMC)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesGeorge macdonaldCompany overviewCompany presentationBlueprint medicines corporationBiotechnology molecular engineeringMedicines corporationOctober companyCogent biosciencesGreater chinaAnalyst commentaryRoyalty pharma

LABU – BUY As The Biotech Sector Starts A New Bull Market (Technical Analysis)

LABU – BUY As The Biotech Sector Starts A New Bull Market (Technical Analysis)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Alpha quantBlueprint medicines corpFund type miscellaneousTg therapeutics incMirati therapeutics incImmunogen incImmunovant incApellis pharmaceuticals incBiohaven ltdGoldman sachs sterling fixinc port incFund detailsBiotechnology molecular engineeringDaily biotech bullDirexion daily biotech bullSachs sterling fixinc port incSachs fin gov

Olema Pharmaceuticals Stock: Advancing On Multiple Fronts (NASDAQ:OLMA)

Olema Pharmaceuticals Stock: Advancing On Multiple Fronts (NASDAQ:OLMA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesWilliam shakespeareEuropean society for medical oncologyCompany websitePipeline company websiteOlema pharmaceuticals incOlema pharmaceuticalsJp morganEarly stage pipeline company websiteCompany overviewBiotechnology molecular engineeringSeeking alphaEuropean societyMedical oncologySan antonio breast cancer symposium

Taysha Gene stock soars 36% as Astellas to pick 15% stake for $50M

Japan's Astellas Pharma (ALPMF) (ALPMY) is acquiring a 15% stake in Taysha Gene Therapies (TSHA) for $50M to support the advancement of Taysha's gene therapy programs for Rett.

Astellas pharmaNaoki okamuraBiotechnology molecular engineeringTaysha gene therapiesAstellas chief strategy officer naoki